Literature DB >> 30482963

FDA approves first new flu drug in 20 years.

Asher Mullard.   

Abstract

Year:  2018        PMID： 30482963     DOI： 10.1038/nrd.2018.219

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Influenza viruses that require 10 genomic segments as antiviral therapeutics.

Authors:  Alfred T Harding; Griffin D Haas; Benjamin S Chambers; Nicholas S Heaton
Journal:  PLoS Pathog       Date:  2019-11-15       Impact factor: 6.823

2.  FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Authors:  Robert Meineke; Sonja Stelz; Maximilian Busch; Christopher Werlein; Mark Kühnel; Danny Jonigk; Guus F Rimmelzwaan; Husni Elbahesh
Journal:  Viruses       Date:  2022-09-16       Impact factor: 5.818

Review 3.  Host Protective Immune Responses against Influenza A Virus Infection.

Authors:  Hi Eun Jung; Heung Kyu Lee
Journal:  Viruses       Date:  2020-05-03       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.